Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017

Resource Information

The instance Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017 represents a material embodiment of a distinct intellectual or artistic creation found in Indiana State Library.

Image

https://evergreen.lib.in.us/opac/extras/ac/jacket/large/r/21659778

Label

Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017

Title remainder

hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017

Instantiates

• Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017

Publication

• Washington, U.S. Government Publishing Office, 2018

Note

• Shipping list no.: 2019-0072-P
• "Serial No. 115-10."

Bibliography note

Includes bibliographical references

Carrier category

volume

Carrier category code

nc

Carrier MARC source

rdacarrier

Content category

text

Content type code

txt

Content type MARC source

rdacontent

Control code

21659778

Dimensions

24 cm

Extent

v, 136 pages

Media category

unmediated

Media MARC source

rdamedia

Media type code

n

Other physical details

illustrations

Record ID

21659778

System control number

• (OCoLC)1078699092
• tmp97457281